Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C - Wikidata - awgldk - TriplyDB

Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C

Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C

http://www.wikidata.org/entity/Q28647320

about

The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1 The cytoplasmic domain of the integrin alpha9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillin-independent manner Spermidine/spermine N1-acetyltransferase specifically binds to the integrin alpha9 subunit cytoplasmic domain and enhances cell migration The evolution of tenascins and fibronectin Tenascin-C and integrins in cancer Fertilin beta and other ADAMs as integrin ligands: insights into cell adhesion and fertilization Molecular modelling and experimental studies of mutation and cell-adhesion sites in the fibronectin type III and whey acidic protein domains of human anosmin-1 Osteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1.Epitopes in α8β1 and other RGD-binding integrins delineate classes of integrin-blocking antibodies and major binding loops in α subunits The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1 Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin alpha9beta1-dependent cellular activities.Polymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding site Integrin α9β1 in airway smooth muscle suppresses exaggerated airway narrowing.Phylogenetic analysis of the tenascin gene family: evidence of origin early in the chordate lineage.Extracellular matrix regulation of inflammation in the healthy and injured spinal cord RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction.Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1.Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles.Duplication and diversification of the spermidine/spermine N1-acetyltransferase 1 genes in zebrafish Short form of α9 promotes α9β1 integrin-dependent cell adhesion by modulating the function of the full-length α9 subunit.Expression of ADAMs and their inhibitors in sputum from patients with asthma.Association of p75(NTR) and α9β1 integrin modulates NGF-dependent cellular responses.Polydom/SVEP1 is a ligand for integrin α9β1.The interaction of versican with its binding partners.The alpha9beta1 integrin enhances cell migration by polyamine-mediated modulation of an inward-rectifier potassium channel The Phosphorylation and Distribution of Cortactin Downstream of Integrin α9β1 Affects Cancer Cell Behaviour Identification of the active site in the heparin II domain of fibronectin that increases outflow facility in cultured monkey anterior segments.Friend or foe? Resolving the impact of glial responses in glaucoma Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis.Integrin alpha8beta1 regulates adhesion, migration and proliferation of human intestinal crypt cells via a predominant RhoA/ROCK-dependent mechanism.Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function Limbal epithelial stem cells: role of the niche microenvironment.Influence of the extracellular matrix on endogenous and transplanted stem cells after brain damage Role of tenascins in the ECM of gliomas.Effects of Ethanol on Brain Extracellular Matrix: Implications for Alcohol Use Disorder.The role of α9β1 integrin in modulating epithelial cell behaviour.Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion.Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma.Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin.

P2860

Q24538981-42591308-3C93-4DF6-A8DD-40C68E6D60C9 Q24555127-F7D6B75F-461F-404F-91BF-338E71423573 Q24676154-E9FC29C2-EE1D-48BD-8346-48FD2B82F3C5 Q27013888-65209003-BA45-4470-8F7C-31A842233594 Q28082328-D08C8DBE-A151-4DA3-B617-DED385A934A4 Q28207538-19683031-E35E-4BCE-84CF-48F7F50D8721 Q28344392-C344F991-A7A2-444B-B91C-9917088D945E Q28509843-3D286F54-51C0-4851-BE90-AD16305A84AA Q28607846-E736B6F6-D702-4A06-9864-43D6D14C036A Q28647112-B6D44F11-E2C7-43EC-94E8-3AE3957D8ACB Q30365463-12500391-4D0D-440B-BACA-80FF83E03A13 Q30487764-AB52F7DB-FB15-4D1B-9F21-9841D4CD04CA Q30525167-29F2ED10-D057-41B2-8AE7-2339D9DD0FE5 Q33253129-864A7DD8-AEB4-4A79-89F2-9A7C816BC2A7 Q33906928-0CE5A3D7-DAEC-453E-9EA6-F18B4756A798 Q33914018-76929D1E-7F25-4F98-883C-F0A392CAB2A1 Q33964642-830B38FE-5827-4810-85D7-357CA9C19B34 Q33977444-DF0AC692-391A-4DFE-8D6F-73CC7CB54FBB Q34552060-0624B0D3-739B-4E53-B9B3-037EDD5C6271 Q35056329-33176112-8722-42CB-95EF-56B8F16BDAD1 Q35113726-2A11F226-6537-4FF3-BB9D-473A28B0B2D6 Q35535596-5BEBB1B0-9332-47A8-A172-4F061493BEB0 Q36127186-6B193AFD-A0D1-4E49-971A-931612706418 Q36208033-27C956B1-5B32-46BE-81B4-1FF21BB158CB Q36660603-2A659F67-3260-4DCB-9EEA-24811DF136F5 Q37035283-657FAE51-196F-4DD9-B8D6-4692A075914D Q37161884-FC6762C8-6C9D-438E-9EE5-57C68C376365 Q37230041-38FE8768-26AD-496D-8BE9-BF560C337FA0 Q37347702-3119FC01-F0AC-4EE9-8997-66AD86D33FC6 Q37354308-6A689332-78FB-4E82-9AFC-5D6A99A9386C Q37434526-F0677EB3-F800-4630-A738-1C78DD89153F Q37781426-DA67A4B3-FDD6-4869-8EF2-287AF2FD98C1 Q37963313-DCA6C2A6-9287-4E37-A3A0-E18ED5C2EBBE Q38246263-C147F009-D514-4C4C-9435-0AD1C949C7A8 Q38361238-20C02E71-A351-471A-94ED-2B82B4699111 Q38942800-B5FB7539-7276-400D-B2D8-FF046EF28263 Q39536007-342646E0-2157-4434-BE03-6ECEAAF3B2EA Q39588142-D5ED7057-1DD6-4B07-B34B-D8FC40956DBA Q39905965-94D3FC1F-D918-4F67-B387-0FF5B53D47FB Q40864152-C8757E70-F433-4BAC-87DA-96565F107C7B

P2860

Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C

http://www.wikidata.org/entity/Q28647320

description

1998 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի մայիսին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique Journal of Biological Chemistry

@fr

artículu científicu espublizáu en 1998

@ast

im Mai 1998 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 1998/05/08)

@sk

vědecký článek publikovaný v roce 1998

@cs

wetenschappelijk artikel (gepubliceerd op 1998/05/08)

@nl

наукова стаття, опублікована в травні 1998

@uk

name

Identification of the ligand b ...... type III repeat of tenascin-C

@ast

Identification of the ligand b ...... type III repeat of tenascin-C

@en

Identification of the ligand b ...... type III repeat of tenascin-C

@nl

type

label

Identification of the ligand b ...... type III repeat of tenascin-C

@ast

Identification of the ligand b ...... type III repeat of tenascin-C

@en

Identification of the ligand b ...... type III repeat of tenascin-C

@nl

prefLabel

Identification of the ligand b ...... type III repeat of tenascin-C

@ast

Identification of the ligand b ...... type III repeat of tenascin-C

@en

Identification of the ligand b ...... type III repeat of tenascin-C

@nl

P1433

Q28647320-3AF1DE45-6ACB-468C-937B-72DD28735F71

P1476

Q28647320-FC318CAC-A743-47BD-AD22-C4E2E182EC55

P2093

Q28647320-01AFB2D2-3483-48F4-9798-D3527CFB5E98

Q28647320-3AD93F54-1A41-46D6-9341-2FC5F40D6C8C

Q28647320-6C62AF67-6BC8-431E-B644-CD08A859538B

Q28647320-7676700E-6A4F-42C1-9CD1-9A8DB7FE8E48

Q28647320-A042EC59-2231-4A6A-93AA-29C156EF39B9

Q28647320-ABCAFC1D-7829-494E-A633-87D701A6CD18

Q28647320-D5AAA37E-3D14-4DEF-BE55-1B588CCFE6A1

Q28647320-D9598C6A-51B4-41BA-869B-63916BD1C0BB

Q28647320-F4E152BF-8429-4741-BDED-39D44349E49C

P2860

Q28647320-078DB996-4388-439F-924F-CB24CB46933F

Q28647320-09689C9F-5631-4DA7-B104-31E959B7291F

Q28647320-0B94932F-DD5E-4239-A55F-0C8DC2BB12A5

Q28647320-1AFD82BA-3BE7-4146-8F7E-F615F80A8D83

Q28647320-207D6678-A35D-41E4-9E22-32A001B10B1C

Q28647320-25401814-CE52-4DB5-B89D-D46CE99C2C9F

Q28647320-34806FD7-1608-44F0-A1A0-45D079376B91

Q28647320-47CE384E-2066-47AA-9713-872E98165FF4

Q28647320-4828C4CB-FC3C-4623-85F8-F3DC7A9FBD43

Q28647320-4DA3905A-9595-45A2-8F11-E0BF271903A1

P304

Q28647320-51252B00-A5AA-4E27-9008-82F91AE62CA2

P31

Q28647320-244E9566-CDBC-407E-91DB-452E78DBEAB7

P3181

Q28647320-1359D219-1440-4BB6-9ADD-8EF86B4D3314

P356

Q28647320-E9D7D8BE-38D7-4737-82D9-DD6D93F29C0E

P407

Q28647320-29F818B5-D778-48FA-9634-DC44C669E94D

P433

Q28647320-5A49DA12-48FA-4F1F-9F86-C9C093D54856

P478

Q28647320-D510446A-EDFB-49A5-B10D-97AEF49B36A9

P577

Q28647320-B51F44A8-95A4-416F-BE74-5C94CE0FB238

P5875

Q28647320-AAC0013A-3FEB-43F1-A81C-38CB0A9752C7

P698

Q28647320-7FE58679-F97F-47BE-84E4-B5737BB9A704

P921

Q28647320-AC382E0D-5E97-4A51-9706-F92D8E024385

Q28647320-CA12C334-7AB6-4CBE-B6FE-88AF0296C8CE

P3181

P356

JBC.273.19.11423

P1433

Journal of Biological Chemistry

P1476

Identification of the ligand b ...... type III repeat of tenascin-C

@en

P2093

D. Sheppard

http://www.w3.org/2001/XMLSchema#string

I. Murakami

http://www.w3.org/2001/XMLSchema#string

J. Chen

http://www.w3.org/2001/XMLSchema#string

M. Obara

http://www.w3.org/2001/XMLSchema#string

M. Yamakido

http://www.w3.org/2001/XMLSchema#string

N. Matsuura

http://www.w3.org/2001/XMLSchema#string

N. Shigeto

http://www.w3.org/2001/XMLSchema#string

S. Higashiyama

http://www.w3.org/2001/XMLSchema#string

Y. Yokosaki

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle

Multiple integrins mediate cell attachment to cytotactin/tenascin

Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein

Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 A resolution

2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region

Integrins: versatility, modulation, and signaling in cell adhesion

Integrins: a family of cell surface receptors

Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains

The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin

RGD and other recognition sequences for integrins

P304

11423–11428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

498124

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.273.19.11423

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

273

http://www.w3.org/2001/XMLSchema#string

P577

1998-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

247482807

http://www.w3.org/2001/XMLSchema#string

P698

9565552

http://www.w3.org/2001/XMLSchema#string

P921

alpha9-beta1 integrin-tenascin complex